Drugs logo Adis International logo

Publisher: Adis International

Volume 68, Number 15, 2008
Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content

< previous issue | next issue > | all issues

Current Opinion

Androgen Replacement Therapy in Androgen-Deficient Women with Hypopituitarism
pp. 2085-2093(9)
Authors: Zang, Hong; Davis, Susan R.

Therapy In Practice

Treatment Options for Proliferative Lupus Nephritis: An Update of Clinical Trial Evidence
pp. 2095-2104(10)
Authors: Navaneethan, Sankar D.; Viswanathan, Gautham; Strippoli, Giovanni F.M.

The Short-Term Medical Management of Non-Variceal Upper Gastrointestinal Bleeding
pp. 2105-2111(7)
Authors: Kovacs, Thomas O.G.; Jensen, Dennis M.

Review Article

Tolerance-Inducing Immunosuppressive Strategies in Clinical Transplantation: An Overview
pp. 2113-2130(18)
Authors: Golshayan, Dela; Pascual, Manuel

New Drugs for Type 2 Diabetes Mellitus: What is their Place in Therapy?
pp. 2131-2162(32)
Authors: Krentz, Andrew J.; Patel, Mayank B.; Bailey, Clifford J.

Pathogenesis and Treatment of Pruritus in Cholestasis
pp. 2163-2182(20)
Authors: Kremer, Andreas E.; Beuers, Ulrich; Oude-Elferink, Ronald P.J.; Pusl, Thomas

Topical Fenticonazole in Dermatology and Gynaecology: Current Role in Therapy
pp. 2183-2194(12)
Authors: Veraldi, Stefano; Milani, Rodolfo

Adis Drug Profile

Ambrisentan
pp. 2195-2204(10)
Authors: Croxtall, Jamie D.; Keam, Susan J.

Adis Drug Evaluation

Pregabalin: A Review of its Use in Fibromyalgia
pp. 2205-2223(19)
Authors: Lyseng-Williamson, Katherine A.; Siddiqui, M. Asif A.

< previous issue | next issue > | all issues

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages.
Page Help Click here for Page Help
Shopping cart
Tools
Sign in






Need to register?
Sign up here
Text size: A | A | A | A